Sharon A. Riddler - Concepedia

Author

Sharon A. Riddler

Also Known As

Bosch, Ronald J, Bosch, Ronald J., Campbell, Thomas B., Cheryl Richards, Chmiel, Joan S., Deborah McMahon, DʼArminio Monforte, Antonella, Elharrar, Vanessa, Lalama, Christina M., Li, Xiuhong

150

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

University of Pittsburgh University of California San Diego Johns Hopkins University Harvard University University of North Carolina at Chapel Hill

About

Sharon A. Riddler is an author at University of Pittsburgh specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	841
2	Cell Biology	2	2	85
3	Health Sciences	1	1	79
4	Allergy	1	1	83
5	Biomedical Engineering	1	1	31

Sharon A. Riddler

Publications

6.1K

Citations

H-Index

Page 1

	Year	Citations
Class-Sparing Regimens for Initial Treatment of HIV-1 Infection Sharon A. Riddler, Richard Haubrich, A. Gregory DiRienzo, New England Journal of Medicine	2008	674
Impact of HIV Infection and HAART on Serum Lipids in Men Sharon A. Riddler JAMA	2003	622
Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003 Eric C. Seaberg, Álvaro Muñoz, Ming‐Chi Lu, AIDS	2005	319
Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study Todd T. Brown, Xiuhong Li, Stephen R. Cole, AIDS	2005	265
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment Richard Haubrich, Sharon A. Riddler, A. Gregory DiRienzo, AIDS	2009	255
High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors Pushpa Gupta, John W. Mellors, Lawrence Kingsley, Journal of Virology	1997	253
HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy Guillaume Besson, Christina M. Lalama, Ronald J. Bosch, Clinical Infectious Diseases	2014	222
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis Roger Detels, Patrick M. Tarwater, John Phair, AIDS	2001	187
Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation Rajesh T. Gandhi, Deborah K. McMahon, Ronald J. Bosch, PLoS Pathogens InflammationPrimary ImmunodeficiencyAntiretroviral TherapyViral PersistenceAutoimmune Disease	2017	182
HLA-Associated Immune Escape Pathways in HIV-1 Subtype B Gag, Pol and Nef Proteins Zabrina L. Brumme, Mina John, Jonathan M. Carlson, PLoS ONE	2009	165

Page 1